The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Screening for and validated quantification of amphetamines and of amphetamine‐ and piperazine‐derived designer drugs in human blood plasma by gas chromatography/mass spectrometry
Abstract
The classical stimulants amphetamine, methamphetamine, ethylamphetamine and the amphetamine‐derived designer drugs MDA, MDMA (‘ecstasy’), MDEA, BDB and MBDB have been widely abused for a relatively long time. In recent years, a number of newer designer drugs have entered the illicit drug market. 4‐Methylthioamphetamine (MTA), p‐methoxyamphetamine (PMA) and p‐methoxymethamphetamine (PMMA) are also derived from amphetamine. Other designer drugs are derived from piperazine, such as benzylpiperazine (BZP), methylenedioxybenzylpiperazine (MDBP), trifluoromethylphenylpiperazine (TFMPP), m‐chlorophenylpiperazine (mCPP) and p‐methoxyphenylpiperazine (MeOPP). A number of severe or even fatal intoxications involving these newer substances, especially PMA, have been reported. This paper describes a method for screening for and simultaneous quantification of the above‐mentioned compounds and the metabolites p‐hydroxyamphetamine and p‐hydroxymethamphetamine (pholedrine) in human blood plasma. The analytes were analyzed by gas chromatography/mass spectrometry in the selected‐ion monitoring mode after mixed‐mode solid‐phase extraction (HCX) and derivatization with heptafluorobutyric anhydride. The method was fully validated according to international guidelines. It was linear from 5 to 1000 µg l−1 for all analytes. Data for accuracy and precision were within required limits with the exception of those for MDBP. The limit of quantification was 5 µg l−1 for all analytes. The applicability of the assay was proven by analysis of authentic plasma samples and of a certified reference sample. This procedure should also be suitable for confirmation of immunoassay results positive for amphetamines and/or designer drugs of the ecstasy type. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ILLEGAL OR LEGITIMATE USE? PRECURSOR COMPOUNDS TO AMPHETAMINE AND METHAMPHETAMINE
MUSSHOFF, F. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100100562 · Cited by 116
Cited by
Peters, F. T., Drummer, O. H., & Musshoff, F. (2007) · Forensic Science International · doi:10.1016/j.forsciint.2006.05.021 · Cited by 1,343
Self-citation
Metadata
- Authors
- Peters, F. T., Schaefer, S., Staack, R. F., Kraemer, T., & Maurer, H. H.
- Venue
- Journal of Mass Spectrometry
- Publisher
- Wiley
- Published
- 2003-06
- Volume
- 38
- Issue
- 6
- Pages
- 659-676
- ISSN
- 1076-5174 (ISSN-L)
- 1096-9888
- OpenAlex
- W2140888184
- Cited by
- 169
- References
- 1
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for and validated quantification of amphetamines and of amphetamine‐ and piperazine‐derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. https://app.cochat.ai/papers/10.1002/jms.483
- The paper
- Peters, F. T., Schaefer, S., Staack, R. F., Kraemer, T., & Maurer, H. H. (2003). Screening for and validated quantification of amphetamines and of amphetamine‐ and piperazine‐derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.483
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.